Bavarian Nordic (BAVN) Withdrawn

Developing vaccines that stimulate T-cell responses for infectious diseases and cancers.

Health Care -

IPO Performance
Latest Trade ()
First Day Return
Return from IPO
 
Bavarian Nordic IPO News more
  • .
IPO Data
IPO File Date 01/04/2016
Offer Price
Price Range n/a
Offer Shares (mm) n/a
Deal Size ($mm) $86
 
IPO Data
IPO Date
Offer Price
Price Range n/a
Offer Shares (mm) n/a
Deal Size ($mm) $$86
 
Underwriters
more
Business Overview
Developing vaccines that stimulate T-cell responses for infectious diseases and cancers.
Developing vaccines that stimulate T-cell responses for infectious diseases and cancers.
more
Company Data
Headquarters Kvistgaard, , Denmark
Founded 1992
Employees 400
Website www.bavarian-nordic.com
 

Performance vs. IPO Index (IPOUSA)